Radiation technology supply company Mirion Technologies has appointed Michael Rossi as its new president.
Rossi will report to the company's CEO, Tom Logan. He comes to his new position from Novartis. Prior to his tenure there, he served at Jubilant Pharma, GE Healthcare, Tyco Healthcare/Mallinckrodt and Syncor International.
Mirion is headquartered in Atlanta and employs 2,800 people, it said.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
